LSBCF.D

LakeShore Biopharma Co., Ltd.

Healthcare · Biotechnology

$161.83 sample

+1.84 (+1.15%) 1D

Market cap

$432.5B

Price as of

2026-10-24

Latest filing

8-K · 2026-08-28

Alerts

8

Price$161.83 -1.92% 3M daily closessample

168.83149.84

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 16INSInsider sell: EVP, Operations
Oct 12INSInsider sell: 10% owner
Oct 01INSInsider sell: EVP, Operations
Sep 22INSInsider sell: General Counsel
Sep 16INSInsider sell: General Counsel
Sep 09INSInsider buy: 10% owner
Sep 02INSInsider buy: Director
Aug 28SECForm 144 filed

Sign up to see the real LSBCF.D record →

Company facts

SEC EDGAR registration

Name: LakeShore Biopharma Co., Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -10sample, -100 to +100
Reporting currency: USD

Who is positioning in LSBCF.D

sample

Insiders: 31 insider transactions over 90 days, net selling, $75.3M
Congress: 4 members traded over 90 days
Institutions · 13F: 11 funds hold $5.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.3B +18.1% y/y

Q4 2024Q3 2026

Inventory$10.5B +18.3% y/y

Q4 2024Q3 2026

Accounts receivable$7.8B +17.2% y/y

Q4 2024Q3 2026

Total debt$19.9B +5.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $296.1B +8.4% 3M
Sample peer B: $348.5B +8.9% 3M
Sample peer C: $54.7B -10.0% 3M
Sample peer D: $388.2B +9.3% 3M
Sample peer E: $162.7B -7.6% 3M